Integrative bioinformatics analysis of immune activation and gene networks in pediatric septic arthritis

C V Elizondo-Solis1, S E Rojas-Gutiérrez1, R Martínez-Canales1

  • 1Systems Immunology and Immunoinformatics Laboratory, Department of Immunology, Universidad Autónoma de Nuevo León, Faculty of Medicine, Monterrey, Nuevo León, Mexico.

PubMed

Insights

This study reveals key genomic and immune markers in pediatric septic arthritis, highlighting innate immunity and neutrophilic responses. Findings offer potential biomarkers and therapeutic targets for this serious childhood infection.

Area of Science:

  • Pediatric Infectious Diseases
  • Bioinformatics
  • Immunology

Background:

  • Pediatric septic arthritis, often caused by Staphylococcus aureus, results in significant illness due to complex inflammation.
  • Identifying genomic and immune profiles is crucial for understanding disease mechanisms and finding treatments.

Purpose of the Study:

  • To map the genomic and immune landscape of pediatric septic arthritis using bioinformatics.
  • To identify potential biomarkers and therapeutic targets for pediatric septic arthritis.

Main Methods:

  • Integrative bioinformatics analysis of gene expression datasets.
  • Identification of differentially expressed genes (DEGs) and construction of protein-protein interaction (PPI) networks.
  • Functional enrichment analysis, transcription factor prediction, and immune cell profiling.

Main Results:

  • Identified 576 DEGs, revealing an innate immunity signature with hub genes MPO and ELANE, suggesting a neutrophilic response.
  • Highlighted pathways involved in antimicrobial defense and neutrophil extracellular trap (NET) formation.
  • Detected significant immune cell shifts, including increased plasma cells and decreased CD4+ naïve T cells.

Conclusions:

  • Elucidated the genomic and immunological basis of pediatric septic arthritis, identifying potential biomarkers and pathways.
  • Emphasized the role of innate immunity in disease pathology.
  • Provided a foundation for further research into diagnostic and therapeutic innovations, requiring clinical validation.
Abstract